WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Dual Chamber Syringes & Injectors

Greystone Associates, January 2012

Many drugs including biologicals require special storage and handling prior to their use because of stability issues - a limitation that has a direct impact on the drug delivery sector. Therapeutic proteins must either be stored under special conditions or formulated to retain their efficacy from the time of manufacture until they are dispensed. Liquid protein drugs require refrigeration until dispensed – a distribution strategy referred to as the ‘Cold Chain’. Alternatively, proteins can be formulated as powders (lyophilization). Lyophilized proteins must be reconstituted prior to injection.

The need to reconstitute lyophilized drugs at the point of administration is driving the growth of dual chamber syringes and injectors – devices that allow reconstitution to take place within the device prior to injection. As biological drugs continue to grow in terms of therapeutics and total prescriptions, the impact of specialty devices will increase.

KEY FEATURES

- Provides assessments of dual chamber syringes and injection devices and analyzes their impact on markets for therapeutic injectable lyophilized drugs

- Analyzes therapeutic demand drivers and evaluates the potential of dual chamber syringes and injector systems

- Provides market data and forecasts to 2015

- Profiles dual chamber syringe and injector device suppliers, their product activities, business strategies, and corporate alliances and affiliations

Executive Summary

Injectable Drug Market Dynamics

The Injectable Drug Ecosystem
Therapeutic Demand Drivers
Specialty Injection Device Demand Drivers
Chronic Conditions and Self-Administration
The Growth of Biologicals
Shifting Patient Demographics
Drug Economics, Safety and Compliance
Device Design and Innovation
Competitive Landscape
Technology Market Drivers

Dual Chamber Injection Device Selection Factors

Disposable vs Reusable
Single Dose vs Multiple Dose
Injection Depth and Needle Strategies
Integrated vs Cartridge-based Dual Chamber Devices
Branding/Private Labeling

Dual Chamber Syringe & Injector Device Assessments

Dual Chamber Syringe Devices
Impulse
Liquid Dry
Lyo-Ject
Dual Chamber Pen Injectors & Cartridges
DCP
LyoTwist Trio
LyoTwist Vario
UnoPen Memo
V-LK
MiniQuick
Unifill EZMix Dual Chamber Safety Syringe
Dual Chamber Syringe & Injector Product Profiles

Dual Chamber Syringe Products
Caverject
Lucrin
Lupron Depot
RediPen
Genotropin
Prostap
Xyntha
Dual Chamber Cartridge/ Injector Products
Genotropin
Proteact
Development Stage Dual Chamber Injectable Drug Products

Market Factors
Regulations
Managed Care and Healthcare Economics

Company Profiles

Product Samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought